David Altshuler, EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,243 shares at $301.99 ($680K) on 2022-11-07, disclosed to the SEC on 2022-11-09.
Seasonal sale ($680k) by EVP, Global Research and CSO — this insider has traded VRTX in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $299.72 | 140 | $42K | 6.2% |
| 2 | $300.96 | 210 | $63K | 9.3% |
| 3 | $300.96 | 210 | $63K | 9.3% |
| 4 | $301.99 | 189 | $57K | 8.4% |
| 5 | $301.99 | 189 | $57K | 8.4% |
| 6 | $303.21 | 261 |
| $79K |
| 11.6% |
| 7 | $303.21 | 261 | $79K | 11.6% |
| 8 | $304.58 | 280 | $85K | 12.5% |
| 9 | $304.58 | 280 | $85K | 12.5% |
| 10 | $305.39 | 140 | $43K | 6.3% |
| 11 | $306.57 | 83 | $25K | 3.7% |
| Total | $302.97 avg | 2,243 | $680K | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $611K | — | Filing → |